Ninke Leffers - Concepedia

Author

Ninke Leffers

University Medical Center Groningen

Also Known As

Leffers, N., N Leffers, N. Leffers, Ninke Leffers

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Leiden University Medical Center ISA Pharmaceuticals (Netherlands)Medisch Centrum Leeuwarden

About

Ninke Leffers is an author at University Medical Center Groningen specializing in medicine, ovarian cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	622
2	Immunology	7	7	350
3	Obstetrics	7	7	488
4	Pathology	5	5	373
5	Cell Biology	2	2	90

Ninke Leffers

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer Ninke Leffers, Marloes J.M. Gooden, Renske A. de Jong, Cancer Immunology Immunotherapy	2008	397
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer Renske A. de Jong, Ninke Leffers, H. Marike Boezen, Gynecologic Oncology Tumoral PathologyCancer ImmunosurveillanceMedicineGynecologyPathology	2009	216
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8<sup>+</sup>T lymphocytes Marloes J.M. Gooden, Margit H. Lampen, Ekaterina S. Jordanova, Proceedings of the National Academy of Sciences	2011	202
Immunization with a P53 synthetic long peptide vaccine induces P53‐specific immune responses in ovarian cancer patients, a phase II trial Ninke Leffers, Annechien J.A. Lambeck, Marloes J.M. Gooden, International Journal of Cancer	2009	140
Serum Cytokine Profiling as a Diagnostic and Prognostic Tool in Ovarian Cancer: A Potential Role for Interleukin 7 Annechien J.A. Lambeck, Anne P.G. Crijns, Ninke Leffers, Clinical Cancer Research	2007	101
Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study Renee Vermeij, Ninke Leffers, Baukje‐Nynke Hoogeboom, International Journal of Cancer ImmunodeficienciesImmunologyImmune RegulationGynecologyImmunodominance	2011	93
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer Claudia B.M. Bijen, E.J. Bantema-Joppe, Renske A. de Jong, International Journal of Cancer	2009	75
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy Fenne L. Komdeur, Maartje C.A. Wouters, Hagma H. Workel, Oncotarget Checkpoint InhibitionLymphocyte DevelopmentT-regulatory CellImmunologyImmune Regulation	2016	68
Long‐term clinical and immunological effects of p53‐SLP® vaccine in patients with ovarian cancer Ninke Leffers, Renee Vermeij, Baukje‐Nynke Hoogeboom, International Journal of Cancer ImmunologyImmunoeditingGynecologyPathologyImmunotherapeutics	2011	57
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer Ninke Leffers, Rudolf S.N. Fehrmann, Marloes J.M. Gooden, British Journal of Cancer	2010	47

Page 1